Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases.
Castellano I, Sapino A, Arisio R, Viale G, Bussolati G, Bandelloni R, Barresi G, Bersiga A, Bordi C, Botti G, Cosimi F, D'Amore E, Doglioni C, Marchetti A, Nappi O, Romeo F, Roncalli M, Russo R, Santinelli A, Spagnoli LG, Tanda F, Tricomi P, Trentini G, Zanconati F, Iurlaro M.
Castellano I, et al. Among authors: sapino a.
Oncol Rep. 2008 May;19(5):1271-5.
Oncol Rep. 2008.
PMID: 18425387